Created at 4:09 p.m. Feb, 11, 2025
Author: friyaz
Related Note: 1503263785726 1
Rationale for change

tx for tuberculoid form for 12mo and lepromatous form for 24mo


National Hansen's Disease (Leprosy) Program: Recommended treatment regimens. https://www.hrsa.gov/hansens-disease/diagnosis/recommended-treatment (Accessed June 11, 2024).

National Hansen's Disease (Leprosy) Program: Hansen's disease cardinal signs & symptoms. https://www.hrsa.gov/hansens-disease/diagnosis (Accessed June 11, 2024).

Guidelines for the Diagnosis, Treatment, and Prevention of Leprosy. World Health Organization 2018. https://www.who.int/publications/i/item/9789290226383 (Accessed January 5, 2023).
Source: Society Guidelines - https://www.hrsa.gov/sites/default/files/hrsa/hansens-disease/hansens-disease-guide-management.pdf

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#PANCE::INFECTIOUS_DISEASE::mycobacterial_diseases #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #AK_Step1_v12::#Bootcamp::Microbiology::34_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step2_v12::#Resources_by_rotation::IM::uw::infectious_disease::infectious_disease_dorian #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::ID #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::08_Mycobacteria #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::19_Mycobacteria::*Mycobacterium_Leprae #AK_Step1_v12::#Bootcamp::Microbiology::08_Mycobacteria::06_Mycobacterium_Leprae #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Step1_v12::#Pixorize::04_Microbiology::06_Bacteria-Gram_Indeterminate::05_Mycobacterium_leprae #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::02_Mycobacterium_Leprae #AK_Step2_v12::#Resources_by_rotation::IM::uw::infectious_disease::infectious_disease_zanki #AK_Step1_v12::#AMBOSS::F-0g_i #AK_Step2_v12::#AMBOSS::-R0Dpf #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#UWorld::COMLEX::24425 #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step2_v12::Original_decks::Dorian::im::uw::infectious_dz #AK_Step1_v12::#Pixorize::04_Microbiology::01_Antibiotics/Antiparasitics::22_Dapsone #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::42_Mycobacterium_Leprae #AK_Step1_v12::#UWorld::Step::1314 #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::21_Leprosy